Estradiol Unknown Status Phase 4 Trials for Menstrual Bleeding / Menstrual Migraines / Menstrual Spotting Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01251263Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.